Pulmonx
Stock Forecast, Prediction & Price Target
Pulmonx (LUNG) stock Price Target by analysts
$10
Potential upside: 553.59%
Pulmonx price prediction
What is Pulmonx stock analysts` prediction?
Pulmonx stock forecast: Based on 1 Wall Street analysts` predicted price targets for Pulmonx in the last 3 months, the avarage price target is $10, with a high forecast of $NaN. The average price target represents a 553.59% change from the last price of $1.53.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Pulmonx stock Price Target by analysts
Full breakdown of analysts given Pulmonx price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Jason Bednar Piper Sandler | 0% 0/1 | 10 months ago | $10 553.59% upside | $6.79 | TheFly | Previous targets (0) |
William Plovanic Canaccord Genuity | 0% 0/1 | about 1 year ago | $16 945.75% upside | $7.42 | TheFly | Previous targets (0) |
Frank Takkinen Loop Capital Markets | 0% 0/1 | over 1 year ago | $12 684.31% upside | $7 | StreetInsider | Previous targets (0) |
Unknown Morgan Stanley | N/A | over 2 years ago | $9.5 520.91% upside | $7.88 | Benzinga | N/A |
Unknown Wells Fargo | N/A | over 2 years ago | $6 292.15% upside | $6.22 | Benzinga | N/A |
Unknown Citigroup | N/A | over 2 years ago | $10 553.59% upside | $5.88 | Benzinga | N/A |
Unknown Stifel Nicolaus | N/A | about 3 years ago | $20 1207.18% upside | $16.37 | Benzinga | N/A |
Unknown Morgan Stanley | N/A | about 3 years ago | $19 1141.83% upside | $16.21 | Benzinga | N/A |
Pulmonx Financial Estimates
Pulmonx Revenue Estimates
Pulmonx EBITDA Estimates
Pulmonx Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $48.41M N/A | $53.66M 10.83% | $68.67M 27.97% | Avg: $98.17M Low: $97.40M High: $98.95M avg. 42.95% | Avg: $118.16M Low: $116.35M High: $119.87M avg. 20.36% | Avg: $143.7M Low: $141.50M High: $145.78M avg. 21.61% | Avg: $147.5M Low: $145.24M High: $149.63M avg. 2.64% |
Net Income
% change YoY
| $-48.66M N/A | $-58.92M -21.08% | $-60.84M -3.25% | Avg: $-61.40M Low: $-64.55M High: $-52.40M avg. -0.92% | Avg: $-49.92M Low: $-61.13M High: $-34.71M avg. 18.69% | Avg: $-28.48M Low: $-29.01M High: $-27.91M avg. 42.95% | Avg: $-29.24M Low: $-29.79M High: $-28.65M avg. -2.66% |
EBITDA
% change YoY
| $-47.48M N/A | $-57.50M -21.08% | $-55.09M 4.19% | Avg: $-83.97M Low: $-84.64M High: $-83.31M avg. -52.43% | Avg: $-101.07M Low: $-102.54M High: $-99.53M avg. -20.36% | Avg: $-122.92M Low: $-124.70M High: $-121.04M avg. -21.61% | Avg: $-126.17M Low: $-128.00M High: $-124.24M avg. -2.64% |
EPS
% change YoY
| -$1.35 N/A | -$1.59 -17.77% | -$1.6 -0.62% | Avg: -$1.56 Low: -$1.7 High: -$1.38 avg. 2.40% | Avg: -$1.24 Low: -$1.61 High: -$0.91 avg. 20.66% | Avg: -$0.75 Low: -$0.76 High: -$0.74 avg. 39.45% | Avg: -$0.77 Low: -$0.78 High: -$0.75 avg. -2.66% |
Operating Expenses
% change YoY
| $82.93M N/A | $98.50M 18.77% | $112.68M 14.40% | Avg: $133.91M Low: $132.86M High: $134.97M avg. 18.83% | Avg: $161.18M Low: $158.71M High: $163.51M avg. 20.36% | Avg: $196.02M Low: $193.02M High: $198.86M avg. 21.61% | Avg: $201.20M Low: $198.12M High: $204.12M avg. 2.64% |
FAQ
What is Pulmonx stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 14.51% in 2025-2028.
We have gathered data from 4 analysts. Their low estimate is -64.55M, average is -61.40M and high is -52.40M.
What is Pulmonx stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 21.89% in 2025-2028.
We have gathered data from 4 analysts. Their low revenue estimate is $97.40M, average is $98.17M and high is $98.95M.
What is Pulmonx stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 14.96% in 2025-2028.
We have gathered data from 4 analysts. Their low earnings per share estimate is -$1.7, average is -$1.56 and high is $-1.38.
What is the best performing analyst?
In the last twelve months 1 analysts have been covering Pulmonx stock. The most successful analyst is Jason Bednar.